Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Lucas

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Immunology, Immunotherapy : CII|October 26, 2017
A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in miceTimothy S Fisher, Andrea T Hooper, Justin Lucas, et al.
Cancers|June 26, 2026
Spatial Biomarker Deep Learning Model Predicts Response to PI3K Inhibition in Head and Neck CancerAntoine Desilets, Minh Tri Le, Catalina Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2015
Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor RegressionsMarc Damelin, Alexander Bankovich, Albert Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2020
A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal CancersDivya Mathur, Adam R Root, Bozena Bugaj-Gaweda, et al.
Science Translational Medicine|January 13, 2017
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressionsMarc Damelin, Alexander Bankovich, Jeffrey Bernstein, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Immunology, Immunotherapy : CII|October 26, 2017
A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in miceTimothy S Fisher, Andrea T Hooper, Justin Lucas, et al.
Cancers|June 26, 2026
Spatial Biomarker Deep Learning Model Predicts Response to PI3K Inhibition in Head and Neck CancerAntoine Desilets, Minh Tri Le, Catalina Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2015
Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor RegressionsMarc Damelin, Alexander Bankovich, Albert Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2020
A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal CancersDivya Mathur, Adam R Root, Bozena Bugaj-Gaweda, et al.
Science Translational Medicine|January 13, 2017
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressionsMarc Damelin, Alexander Bankovich, Jeffrey Bernstein, et al.
Pageof 2